GENEVA, April 15 -- SPARK THERAPEUTICS, INC. (3737 Market Street, Suite 1300Philadelphia, PA 19104) filed a patent application (PCT/US2025/049365) for "IDES FUSION PROTEINS" on Oct 03, 2025. With publication no. WO/2026/076313, the details related to the patent application was published on Apr 09, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): COHEN, Daniel (c/o Spark Therapeutics, Inc.3737 Market Street, Suite 1300Philadelphia, PA 19104), ALEXANDER, Jeffrey (c/o Spark Therapeutics, Inc.3737 Market Street, Suite 1300Philadelphia, PA 19104), ELLIOT, Sarah (c/o Spark Therapeutics, Inc.3737 Ma...